Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | E4A39 | — |
administration of an Expired vaccine - Menveo; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number E4A39, expiry date 30-JUN-2025) for prophylaxis. On 08-JUL-2025, the patient received the 1st dose of Menveo. On 08-JUL-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: administration of an Expired vaccine - Menveo). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt date: 09-JUL-2025 A Medical Assistant called to report the administration of an expired vaccine, Menveo (1 vial) to a patient, which led to expired vaccine used. She called to get some guidance in case the dose should be repeated. The reporter did not consent to follow-up. The Vaccine Administration Facility is the same as Primary Reporter.